investor.insulet.comInvestor Relations | Insulet Corporation

Skip to main navigation Investor Relations ABOUT INSULET INVESTOR RELATIONS PRESS RELEASES EVENTS & PRESENTATIONS CORPORATE GOVERNANCE FINANCIAL INFORMATION STOCK INFORMATION SIGN UP FOR ALERTS INVESTOR CONTACT IR Contact: Deborah R. Gordon, C.P.A. Vice President, Investor Relations 978.600.7717 dgordon@insulet.com ir@insulet.com Jason McGorman Principal Investor Relations Analyst 978-600-7972 jmcgorman@insulet.com Lauren Paige Executive Assistant 978-600-7835 lpaige@insulet.com Insulet Corporation 100 Nagog Park Acton, MA 01720 Investor Relations Investor Relations Stock Quote (: ) Price: Change: Day High: Day Low: Volume: Corporate Profile 3 mo. 6 mo. 1 yr. Insulet Corporation is an innovative medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy. Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional pump technology. The Omnipod System is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. Improvements include Omnipod’s lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with diabetes. View all Recent Release Nov 9, 2020 Summary Toggle Insulet to Present at Upcoming Investor Conferences Nov 4, 2020 Summary Toggle Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year Events & Presentations View all Nov 19, 2020 12:30 PM EST Canaccord Genuity 2020 MedTech & Diagnostics Forum Nov 23, 2020 Piper Sandler 32nd Annual Healthcare Conference Dec 2, 2020 11:30 AM EST Nasdaq 43rd Investor Conference Email Alerts RSS Feed Print Share Customer Care - 1.800.591.3455 About Insulet Contact Information FAQs California Supply Chain Act Privacy Policy Terms of Use Font Size: A A A © 2020 Insulet Corporation. All rights reserved. Facebook Google LinkedIn Twitter RSS...